HighTower Advisors’s Royalty Pharma RPRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$14.1M Buy
292,921
+11,799
+4% +$517K 0.01% 741
2025
Q4
$10.9M Buy
281,122
+61,166
+28% +$2.33M 0.01% 832
2025
Q3
$7.76M Buy
219,956
+13,842
+7% +$501K 0.01% 956
2025
Q2
$7.43M Buy
206,114
+34,720
+20% +$1.15M 0.01% 923
2025
Q1
$5.34M Sell
171,394
-2,017
-1% -$63.9K 0.01% 1018
2024
Q4
$4.42M Sell
173,411
-9,177
-5% -$243K 0.01% 1099
2024
Q3
$5.15M Sell
182,588
-13,624
-7% -$377K 0.01% 1022
2024
Q2
$5.17M Sell
196,212
-28,212
-13% -$782K 0.01% 992
2024
Q1
$6.82M Buy
224,424
+49,028
+28% +$1.45M 0.01% 837
2023
Q4
$4.93M Sell
175,396
-55,748
-24% -$1.53M 0.01% 978
2023
Q3
$6.26M Buy
231,144
+69,527
+43% +$2.07M 0.01% 830
2023
Q2
$4.97M Sell
161,617
-2,454
-1% -$83.1K 0.01% 908
2023
Q1
$5.9M Buy
164,071
+5,118
+3% +$190K 0.01% 784
2022
Q4
$6.29M Sell
158,953
-8,848
-5% -$369K 0.01% 761
2022
Q3
$6.74M Buy
167,801
+792
+0.5% +$33.8K 0.02% 689
2022
Q2
$7.02M Buy
167,009
+15,303
+10% +$627K 0.02% 684
2022
Q1
$5.92M Buy
151,706
+20,430
+16% +$802K 0.01% 811
2021
Q4
$5.24M Buy
131,276
+10,861
+9% +$422K 0.01% 879
2021
Q3
$4.36M Buy
120,415
+2,008
+2% +$78K 0.01% 883
2021
Q2
$4.85M Buy
+118,407
New +$5.04M 0.01% 801

Other funds holding RPRX